Literature DB >> 10974188

A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination.

S Saab1, P Martin, H F Yee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10974188     DOI： 10.1016/s0002-9343(00)00469-1

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.

Authors:  Donghun Lee; Moran Ki; Anna Lee; Kyoung Ryul Lee; Hee Bong Park; Chang Sub Kim; Bo Young Yoon; Jong Hyun Kim; Young Sok Lee; Sook Hyang Jeong
Journal:  Korean J Hepatol       Date:  2011-03

2.  The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis.

Authors:  Eduardo Lopez; Roberto Debbag; Laurent Coudeville; Florence Baron-Papillon; Judith Armoni
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

3.  Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.

Authors:  Barbara Greengold; Adeline Nyamathi; Gerald Kominski; Dorothy Wiley; Mary Ann Lewis; Felicia Hodge; Mendel Singer; Brennan Spiegel
Journal:  Vaccine       Date:  2008-11-27       Impact factor: 3.641

4.  An economic assessment of pre-vaccination screening for hepatitis A and B.

Authors:  R Jake Jacobs; Sammy Saab; Allen S Meyerhoff; Raymond S Koff
Journal:  Public Health Rep       Date:  2003 Nov-Dec       Impact factor: 2.792

5.  Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.

Authors:  Sang Ho Lee; Hyoung Su Kim; Kwon Oh Park; Jong Won Park; Seung Yeon Chun; Seung Jin Lim; Hyun Jung Cho; Sung Jun Kim; Hye Won Park; Han Kook Moon; Woon Geon Shin; Kyung Ho Kim; Myoung Kuk Jang; Jin Heon Lee; Hak Yang Kim
Journal:  Korean J Hepatol       Date:  2010-12

Review 6.  Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea.

Authors:  Hyun Joo Song; Tae Hun Kim; Ji Hyun Song; Hee Jung Oh; Kum Hei Ryu; Hye Jung Yeom; Seong-Eun Kim; Hye-Kyung Jung; Ki-Nam Shim; Sung-Ae Jung; Kwon Yoo; Il-Hwan Moon; Kyu Won Chung
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

7.  Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.

Authors:  Sung Jun Chung; Tae Yeob Kim; Sun Min Kim; Min Roh; Mi Yeon Yu; Jung Hoon Lee; ChangKyo Oh; Eun Young Lee; Seung Lee; Yong Cheol Jeon; Kyo-Sang Yoo; Joo Hyun Sohn
Journal:  Clin Mol Hepatol       Date:  2014-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.